147 related articles for article (PubMed ID: 21486110)
21. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
Dannon PN; Lowengrub K; Gonopolski Y; Musin E; Kotler M
Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432
[TBL] [Abstract][Full Text] [Related]
22. Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity.
Zack M; Poulos CX
J Psychopharmacol; 2009 Aug; 23(6):660-71. PubMed ID: 18583430
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
[TBL] [Abstract][Full Text] [Related]
24. A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
Kovanen L; Basnet S; Castrén S; Pankakoski M; Saarikoski ST; Partonen T; Alho H; Lahti T
Eur Addict Res; 2016; 22(2):70-9. PubMed ID: 26339899
[TBL] [Abstract][Full Text] [Related]
25. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
[TBL] [Abstract][Full Text] [Related]
26. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
[TBL] [Abstract][Full Text] [Related]
27. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
28. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
[TBL] [Abstract][Full Text] [Related]
29. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
[TBL] [Abstract][Full Text] [Related]
30. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
32. Topiramate in essential tremor: a double-blind, placebo-controlled trial.
Ondo WG; Jankovic J; Connor GS; Pahwa R; Elble R; Stacy MA; Koller WC; Schwarzman L; Wu SC; Hulihan JF;
Neurology; 2006 Mar; 66(5):672-7. PubMed ID: 16436648
[TBL] [Abstract][Full Text] [Related]
33. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
34. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Javors MA
Arch Intern Med; 2005 Jul; 165(14):1600-5. PubMed ID: 16043677
[TBL] [Abstract][Full Text] [Related]
35. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
36. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Bellinghieri PM; Scimeca G; Cacciola M; Campolo D; Settineri S; Zoccali R
J Psychopharmacol; 2011 May; 25(5):667-74. PubMed ID: 20615930
[TBL] [Abstract][Full Text] [Related]
37. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
[TBL] [Abstract][Full Text] [Related]
38. An open-label trial of acamprosate in the treatment of pathological gambling.
Black DW; McNeilly DP; Burke WJ; Shaw MC; Allen J
Ann Clin Psychiatry; 2011 Nov; 23(4):250-6. PubMed ID: 22073381
[TBL] [Abstract][Full Text] [Related]
39. A single-blind study of 'as-needed' ecopipam for gambling disorder.
Grant JE; Odlaug BL; Black DW; Fong T; Davtian M; Chipkin R; Kim SW
Ann Clin Psychiatry; 2014 Aug; 26(3):179-86. PubMed ID: 25166480
[TBL] [Abstract][Full Text] [Related]
40. Self-reported and neuropsychological measures of impulsivity in pathological gambling.
Fuentes D; Tavares H; Artes R; Gorenstein C
J Int Neuropsychol Soc; 2006 Nov; 12(6):907-12. PubMed ID: 17064453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
